Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 12 Mar 2026 for Ironwood Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleThomas A. MCCOURT
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Thomas A. MCCOURT: trading record in brief
Thomas A. MCCOURT is a declared insider at 2 companies (chief executive); the most frequent names are Ironwood Pharmaceuticals Inc and Acceleron Pharma Inc. In total, 32 filings cover trades dated from 24 May 2021 to 10 March 2026.
No open-market purchase appears, only 20 sales worth €7.4M. Outside the open market, there are 9 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 12 March 2026: a share grant, in Ironwood Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas A. MCCOURT
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
409,836 shares0Class A Common StockSEC:0001193125-26-104099:0
94,757 shares@ US$3.813.5% of flowClass A Common StockSEC:0001193125-26-071496:0
13,353 shares@ US$0.580.1% of flowClass A Common StockSEC:0000950170-25-075191:0
139,064 shares@ US$1.762.5% of flowClass A Common StockSEC:0000950170-25-019237:0
147,354 shares0Class A Common StockSEC:0000950170-25-007805:0
67,618 shares@ US$6.454.3% of flowClass A Common StockSEC:0000950170-24-063485:0
120,298 shares0Class A Common StockSEC:0000950170-24-029909:0
264,876 shares0Class A Common StockSEC:0000950170-24-027917:0
177,164 shares@ US$15.2426.8% of flowClass A Common StockSEC:0000950170-24-015542:0
249,617 shares0Class A Common StockSEC:0001209191-24-001906:0
26,632 shares@ US$10.702.8% of flowClass A Common StockSEC:0001209191-23-033396:0
36,000 shares@ US$10.123.6% of flowClass A Common StockSEC:0001209191-23-031875:0
21,148 shares@ US$10.622.2% of flowClass A Common StockSEC:0001209191-23-028453:0
46,129 shares@ US$10.674.9% of flowClass A Common StockSEC:0001209191-23-021524:0
240,595 shares0Class A Common StockSEC:0001209191-23-017882:0
33,756 shares@ US$11.223.8% of flowClass A Common StockSEC:0001209191-23-016696:0
25,595 shares@ US$11.413.0% of flowClass A Common StockSEC:0001209191-23-014283:0
30,145 shares0Class A Common StockSEC:0001209191-23-003990:0
110,962 shares@ US$11.6513.1% of flowClass A Common StockSEC:0001209191-23-002543:0
18,899 shares@ US$10.412.1% of flowClass A Common StockSEC:0001209191-22-052718:0
26,446 shares@ US$10.653.0% of flowClass A Common StockSEC:0001209191-22-048716:0
23,229 shares@ US$11.352.8% of flowClass A Common StockSEC:0001209191-22-044162:0
19,959 shares@ US$11.582.4% of flowClass A Common StockSEC:0001209191-22-040558:0
2,587 shares@ US$11.500.0047% mcap1.3% of flowClass A Common StockSEC:0001209191-22-031844:0
248,869 shares0Class A Common StockSEC:0001209191-22-017840:0
25 of 32 declarations
